Skip to main content
. Author manuscript; available in PMC: 2015 Apr 1.
Published in final edited form as: Laryngoscope. 2013 Oct 22;124(4):E107–E114. doi: 10.1002/lary.24412

Table 1.

Mediators implicated in non-rapid eye movement sleep, rapid eye movement sleep, and chronic rhinosinusitis.

Somnogenic Substances/Immune Mediators Effects NREMS Effects REMS CRS References
Interleukin-1 ↑ ↔ ↓ + Krueger5, Lennard,46 Mullol47
Interleukin-1 Receptor Antagonist Opp 48
Interleukin-4 + Krueger5, Kushikata16,
Interleukin-6 ↑ ↔ ↓ + Bauer49, Vgontzas50, Hogan51, Ghaffar52
Interleukin-10 + Krueger5, Kushikata15, Opp53, Toth54, Jyonouchi 55
Interleukin-13 + Kubota17, al Ghamdi,14 Reh56
Inferferon alpha ↑ ↔ ↓ Bohnet57
Soluble tumor necrosis factor receptor Kubota58
Tissue Growth Factor Beta + Kubota,17 Kuo13
Histamine + Tashiro,59
TLR + Wisor,60 Sartorius,61 Lane62
Prostaglandin ↑ ↔ ↓ Sri Kantha,63 Hayaishi,64 Urade,65 Krueger66

NREMS, non-rapid eye movement sleep; REMS, rapid eye movement sleep; CRS, chronic rhinosinusitis; TLR, toll-like receptor. “↑”,”↔”, and “↓” indicate mean influence on NREMS or REMS.